$1.85 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 87 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FULC | FULCRUM THERAPEUTICS INC | $25,391,832 | +34.5% | 5,718,881 | 0.0% | 1.37% | +36.0% | |
| STRO | SUTRO BIOPHARMA INC | $20,416,415 | -25.4% | 5,883,693 | 0.0% | 1.10% | -24.6% | |
| ZURA BIO LTD | $18,810,000 | -19.5% | 2,850,000 | 0.0% | 1.02% | -18.7% | ||
| IFRX | INFLARX NV | $17,087,052 | -33.2% | 5,733,910 | 0.0% | 0.92% | -32.5% | |
| AGIO | AGIOS PHARMACEUTICALS INC | $11,236,500 | -12.6% | 454,000 | 0.0% | 0.61% | -11.6% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $9,500,125 | -2.3% | 7,364,438 | 0.0% | 0.51% | -1.3% | |
| KZR | KEZAR LIFE SCIENCES INC | $8,529,433 | -51.4% | 7,167,591 | 0.0% | 0.46% | -50.9% | |
| SNY | SANOFIsponsored adr | $6,224,439 | -0.5% | 116,041 | 0.0% | 0.34% | +0.6% | |
| BNTX | BIONTECH SEsponsored ads | $4,450,981 | +0.7% | 40,970 | 0.0% | 0.24% | +2.1% | |
| DHR | DANAHER CORPORATION | $4,075,539 | +3.4% | 16,427 | 0.0% | 0.22% | +4.3% | |
| TMO | THERMO FISHER SCIENTIFIC INC | $3,674,794 | -3.0% | 7,260 | 0.0% | 0.20% | -2.0% | |
| PEPGEN INC | $2,471,984 | -43.2% | 486,611 | 0.0% | 0.13% | -42.5% | ||
| NTRA | NATERA INC | $2,296,575 | -9.1% | 51,900 | 0.0% | 0.12% | -8.1% | |
| ABC | CENCORA INC | $2,247,465 | -6.5% | 12,488 | 0.0% | 0.12% | -5.5% | |
| NRIX | NURIX THERAPEUTICS INC | $2,206,774 | -21.3% | 280,760 | 0.0% | 0.12% | -20.7% | |
| INCY | INCYTE CORP | $2,172,152 | -7.2% | 37,600 | 0.0% | 0.12% | -6.4% | |
| AKILI INC | $2,108,719 | -50.5% | 3,841,718 | 0.0% | 0.11% | -50.0% | ||
| ABT | ABBOTT LABS | $1,997,047 | -11.2% | 20,620 | 0.0% | 0.11% | -10.0% | |
| GILD | GILEAD SCIENCES INC | $1,701,138 | -2.8% | 22,700 | 0.0% | 0.09% | -2.1% | |
| MOLN | MOLECULAR PARTNERS AGads | $1,656,000 | -33.4% | 400,000 | 0.0% | 0.09% | -33.1% | |
| GLPG | GALAPAGOS NVspon adr | $1,630,760 | -15.0% | 47,200 | 0.0% | 0.09% | -14.6% | |
| IQV | IQVIA HLDGS INC | $1,411,681 | -12.5% | 7,175 | 0.0% | 0.08% | -11.6% | |
| MDT | MEDTRONIC PLC | $1,368,166 | -11.1% | 17,460 | 0.0% | 0.07% | -9.8% | |
| ANTM | ELEVANCE HEALTH INC | $1,310,614 | -2.0% | 3,010 | 0.0% | 0.07% | -1.4% | |
| ILMN | ILLUMINA INC | $1,198,454 | -26.8% | 8,730 | 0.0% | 0.06% | -26.1% | |
| CVS | CVS HEALTH CORP | $1,198,809 | +1.0% | 17,170 | 0.0% | 0.06% | +3.2% | |
| SYK | STRYKER CORPORATION | $1,191,457 | -10.4% | 4,360 | 0.0% | 0.06% | -9.9% | |
| CI | THE CIGNA GROUP | $1,144,280 | +1.9% | 4,000 | 0.0% | 0.06% | +3.3% | |
| ISRG | INTUITIVE SURGICAL INC | $897,330 | -14.5% | 3,070 | 0.0% | 0.05% | -14.3% | |
| WAT | WATERS CORP | $863,762 | +2.9% | 3,150 | 0.0% | 0.05% | +4.4% | |
| AVTR | AVANTOR INC | $806,310 | +2.6% | 38,250 | 0.0% | 0.04% | +4.8% | |
| SRPT | SAREPTA THERAPEUTICS INC | $734,351 | +5.9% | 6,058 | 0.0% | 0.04% | +8.1% | |
| DXCM | DEXCOM INC | $548,604 | -27.4% | 5,880 | 0.0% | 0.03% | -25.0% | |
| A | AGILENT TECHNOLOGIES INC | $557,982 | -7.0% | 4,990 | 0.0% | 0.03% | -6.2% | |
| IDXX | IDEXX LABS INC | $402,288 | -12.9% | 920 | 0.0% | 0.02% | -12.0% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $307,183 | +2.3% | 1,360 | 0.0% | 0.02% | +6.2% | |
| OPY ACQUISITION CORP I*w exp 09/22/202 | $2,011 | -81.5% | 72,605 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.